← Back
$SCPH All transactions

scPharmaceuticals Inc.

D

$ Value

$0

Shares

19,750

Price

$0

Filed

Oct 7

Insider

Name

VEITINGER KLAUS R DR

Title

CIK

0001283972

Roles

Director

Transaction Details

Transaction Date

2025-10-07

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the "Merger Agreement"), by and among the Issuer, MannKind Corporation ("Parent") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock ("Common Stock") on October 7, 2025. Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a "Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash, | (Continued from footnote 1) without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option.

Filing Info

Accession No.

0001193125-25-233537

Form Type

4

Issuer CIK

0001604950

VEITINGER KLAUS R DR's History

Date Ticker Type Value
2025-10-07 SCPH D $0
2025-10-07 SCPH D $0
2025-10-07 SCPH D $0
2025-10-07 SCPH D $0
2025-06-03 SCPH A $0

Other Insiders at SCPH (90d)

No other insider activity at this issuer in the last 90 days.